QuidelOrtho PE Ratio 2010-2025 | QDEL
Current and historical p/e ratio for QuidelOrtho (QDEL) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. QuidelOrtho PE ratio as of July 03, 2025 is 14.04.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| QuidelOrtho PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-07-03 | 30.19 | 0.00 | |
| 2025-03-31 | 34.97 | $-4.97 | 0.00 |
| 2024-12-31 | 44.55 | $-30.28 | 0.00 |
| 2024-09-30 | 45.60 | $-27.90 | 0.00 |
| 2024-06-30 | 33.22 | $-27.79 | 0.00 |
| 2024-03-31 | 47.94 | $-26.39 | 0.00 |
| 2023-12-31 | 73.70 | $-0.16 | 0.00 |
| 2023-09-30 | 73.04 | $0.19 | 384.42 |
| 2023-06-30 | 82.86 | $0.66 | 125.55 |
| 2023-03-31 | 89.09 | $1.82 | 48.95 |
| 2022-12-31 | 85.67 | $12.40 | 6.91 |
| 2022-09-30 | 71.48 | $18.80 | 3.80 |
| 2022-06-30 | 97.18 | $23.60 | 4.12 |
| 2022-03-31 | 112.46 | $23.69 | 4.75 |
| 2021-12-31 | 134.99 | $16.47 | 8.20 |
| 2021-09-30 | 141.15 | $20.40 | 6.92 |
| 2021-06-30 | 128.12 | $20.65 | 6.20 |
| 2021-03-31 | 127.93 | $21.75 | 5.88 |
| 2020-12-31 | 179.65 | $18.59 | 9.66 |
| 2020-09-30 | 219.38 | $8.52 | 25.75 |
| 2020-06-30 | 223.74 | $3.57 | 62.67 |
| 2020-03-31 | 97.81 | $2.05 | 47.71 |
| 2019-12-31 | 75.03 | $1.72 | 43.62 |
| 2019-09-30 | 61.35 | $1.79 | 34.27 |
| 2019-06-30 | 59.32 | $1.68 | 35.31 |
| 2019-03-31 | 65.47 | $1.57 | 41.70 |
| 2018-12-31 | 48.82 | $1.83 | 26.68 |
| 2018-09-30 | 65.17 | $0.90 | 72.41 |
| 2018-06-30 | 66.50 | $0.47 | 141.49 |
| 2018-03-31 | 51.81 | $0.20 | 259.05 |
| 2017-12-31 | 43.35 | $-0.24 | 0.00 |
| 2017-09-30 | 43.86 | $-0.15 | 0.00 |
| 2017-06-30 | 27.14 | $-0.01 | 0.00 |
| 2017-03-31 | 22.64 | $0.10 | 226.40 |
| 2016-12-31 | 21.42 | $-0.43 | 0.00 |
| 2016-09-30 | 22.09 | $-0.38 | 0.00 |
| 2016-06-30 | 17.86 | $-0.38 | 0.00 |
| 2016-03-31 | 17.26 | $-0.40 | 0.00 |
| 2015-12-31 | 21.20 | $-0.18 | 0.00 |
| 2015-09-30 | 18.88 | $0.03 | 629.33 |
| 2015-06-30 | 22.95 | $-0.12 | 0.00 |
| 2015-03-31 | 26.98 | $-0.06 | 0.00 |
| 2014-12-31 | 28.92 | $-0.21 | 0.00 |
| 2014-09-30 | 26.87 | $-0.38 | 0.00 |
| 2014-06-30 | 22.11 | $-0.34 | 0.00 |
| 2014-03-31 | 27.30 | $-0.19 | 0.00 |
| 2013-12-31 | 30.89 | $0.21 | 147.10 |
| 2013-09-30 | 28.40 | $0.44 | 64.55 |
| 2013-06-30 | 25.53 | $0.55 | 46.42 |
| 2013-03-31 | 23.75 | $0.50 | 47.50 |
| 2012-12-31 | 18.67 | $0.14 | 133.36 |
| 2012-09-30 | 18.93 | $-0.09 | 0.00 |
| 2012-06-30 | 15.68 | $-0.10 | 0.00 |
| 2012-03-31 | 18.37 | $-0.11 | 0.00 |
| 2011-12-31 | 15.13 | $0.24 | 63.04 |
| 2011-09-30 | 16.37 | $0.20 | 81.85 |
| 2011-06-30 | 15.15 | $0.02 | 757.50 |
| 2011-03-31 | 11.96 | $0.04 | 299.00 |
| 2010-12-31 | 14.45 | $-0.40 | 0.00 |
| 2010-09-30 | 10.99 | $0.28 | 39.25 |
| 2010-06-30 | 12.69 | $0.99 | 12.82 |
| 2010-03-31 | 14.54 | $1.10 | 13.22 |
| 2009-12-31 | 13.78 | $1.10 | 12.53 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $2.041B | $2.783B |
| QuidelOrtho is a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems. The company's brand names include Sofia(R), Solana(R), Lyra(R), Triage(R) and QuickVue(R). Its comprehensive product portfolio includes tests for a range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. QuidelOrtho, formerly known as Quidel Corporation, is based in SAN DIEGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.329B | 28.06 |
| Boston Scientific (BSX) | United States | $153.315B | 38.38 |
| Stryker (SYK) | United States | $149.550B | 31.27 |
| EssilorLuxottica (ESLOY) | France | $129.320B | 0.00 |
| Medtronic (MDT) | Ireland | $113.223B | 16.05 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.710B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.111B | 26.31 |
| ResMed (RMD) | United States | $37.519B | 28.18 |
| GE HealthCare Technologies (GEHC) | United States | $34.854B | 16.55 |
| Agilent Technologies (A) | United States | $34.275B | 22.34 |
| Terumo (TRUMY) | Japan | $25.791B | 33.50 |
| Koninklijke Philips (PHG) | Netherlands | $23.611B | 16.57 |
| Insulet (PODD) | United States | $21.226B | 83.32 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.499B | 11.88 |
| Baxter (BAX) | United States | $15.975B | 11.93 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.209B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.821B | 23.74 |
| Lantheus Holdings (LNTH) | United States | $5.509B | 13.90 |
| Prestige Consumer Healthcare (PBH) | United States | $3.962B | 17.70 |
| Perrigo (PRGO) | Ireland | $3.748B | 9.50 |
| Haemonetics (HAE) | United States | $3.663B | 16.68 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.419B | 28.41 |
| ICU Medical (ICUI) | United States | $3.352B | 24.72 |
| LeMaitre Vascular (LMAT) | United States | $1.894B | 42.35 |
| AtriCure (ATRC) | United States | $1.554B | 0.00 |
| Acuren (TIC) | United States | $1.375B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.264B | 12.84 |
| Green Thumb Industries (GTBIF) | United States | $1.169B | 26.29 |
| Neogen (NEOG) | United States | $1.135B | 14.53 |
| Phibro Animal Health (PAHC) | United States | $1.133B | 14.48 |
| BioLife Solutions (BLFS) | United States | $1.081B | 0.00 |
| InMode (INMD) | Israel | $0.961B | 9.69 |
| Kestra Medical Technologies (KMTS) | United States | $0.783B | 0.00 |
| Owens & Minor (OMI) | United States | $0.718B | 5.96 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.675B | 0.00 |
| CeriBell (CBLL) | United States | $0.673B | 0.00 |
| Evolus (EOLS) | United States | $0.594B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.551B | 0.00 |
| Valneva SE (VALN) | France | $0.494B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.488B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.458B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.359B | 13.21 |
| Quanterix (QTRX) | United States | $0.346B | 0.00 |
| SNDL (SNDL) | Canada | $0.328B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
| Cerus (CERS) | United States | $0.298B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.280B | 23.60 |
| ZimVie (ZIMV) | United States | $0.279B | 12.67 |
| Sanuwave Health (SNWV) | United States | $0.271B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.266B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.251B | 74.50 |
| Cresco Labs (CRLBF) | United States | $0.251B | 0.00 |
| Brainsway (BWAY) | Israel | $0.242B | 64.00 |
| Biote (BTMD) | United States | $0.229B | 6.45 |
| OraSure Technologies (OSUR) | United States | $0.229B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.219B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.187B | 15.21 |
| TriSalus Life Sciences (TLSI) | United States | $0.185B | 0.00 |
| Organigram Global (OGI) | Canada | $0.185B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.182B | 0.00 |
| Omeros (OMER) | United States | $0.181B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.150B | 0.00 |
| Exagen (XGN) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.128B | 15.73 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 12.33 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| MacroGenics (MGNX) | United States | $0.087B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.086B | 0.00 |
| Veru (VERU) | United States | $0.086B | 0.00 |
| Zynex (ZYXI) | United States | $0.081B | 0.00 |
| Apyx Medical (APYX) | United States | $0.081B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.077B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.060B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Nephros (NEPH) | United States | $0.042B | 56.86 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.81 |
| Safety Shot (SHOT) | United States | $0.030B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.028B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |